Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement

European Journal of Pharmaceutical Sciences

Volumn 39, Issue 1-3, 2010, Pages 164-174

  Sanganwar, Ganesh P ^a   Sathigari, Sateeshkumar ^b   Babu, R Jayachandra ^b   Gupta, Ram B ^a  

^a AUBURN UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Dissolution rate enhancement; High pressure stirred bed mixing; Micro mixing; Supercritical antisolvent

Indexed keywords

LACTOSE; MICROCRYSTALLINE CELLULOSE; NEVIRAPINE;

ARTICLE; CRYSTAL STRUCTURE; DRUG MIXTURE; DRUG SOLUBILITY; DRUG SYNTHESIS; PHYSICAL CHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; SURFACE PROPERTY;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, SUPERCRITICAL FLUID; CRYSTALLIZATION; DRUG CARRIERS; DRUG COMPOUNDING; EXCIPIENTS; MICROSPHERES; NEVIRAPINE; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTIES;

EID: 73749083989     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.11.011     Document Type: Article

References (39)

1. Aguiar A.J., Zelmer A.W., and Kinkel A.W. Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt. J. Pharm. Sci. 56 (1967) 1243-1252
2. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutical drug classification: the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm. Res. 12 (1995) 413-420
3. 2 supercritical antisolvent type process: comparison of different introduction devices. Ind. Eng. Chem. Res. 48 (2009) 5671-5678
4. Chattopadhyay P., and Gupta R.B. Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer. AIChE J. 48 (2002) 235-244
5. DeVilliers M.M., and VanderWatt J.G. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing. Pharm. Res. 11 (1994) 1557-1561
6. DeVilliers M.M. Influence of agglomeration of cohesive particles on the dissolution behaviour of furosemide powder. Int. J. Pharm. (Kidlington) 136 (1996) 175-179
7. Fan L.T., and Chen Y.M. Recent development in solids mixing. Powder Technol. 61 (1990) 255-287
8. Finholt P., and Slovang S. Dissolution kinetics of drugs in human gastric juice the role of surface tension. J. Pharm. Sci. 57 (1968) 1322-1326
9. Garcia T.P., Carella A., and Pansa V. Identification of factors decreasing the homogeneity of blend and tablet uniformity. Pharma Technol. 28 3 (2004) 110-122
10. Harnby N., Edwards M.F., and Nienow A.W. Mixing in Process Industries (1990), Butterworth, London
11. Harnby N. An engineering view of pharmaceutical powder mixing. Pharm. Sci. Technol. Today 3 (2000) 303-309
12. Jounela A., Pentikainen P., and Sothmann A. Effect of particle size on the bioavailability of digoxin. Eur. J. Clin. Pharmacol. 8 (1975) 365-370
13. Kale K., Hapgood K., and Stewart P. Drug agglomeration and dissolution-what is the influence of powder mixing. Eur. J. Pharm. Sci. 72 (2009) 156-164
14. Kim M.S., Lee S., Park J.S., Woo J.S., and Hwang S.J. Micronization of cilostazol using supercritical antisolvent process: effect of process parameters. Powder Technol. 177 (2007) 64-70
15. Kothari S.J., Kumar V., and Banker G.S. Comparative evaluations of powder and mechanical properties of low crystallinity cellulose, microcrystalline cellulose, and powdered celluloses. Int. J. Pharm. (Kidlington) 232 (2002) 69-80
16. Krycer I., and Hersey J.A. A comparative study of comminution in rotary and vibratory ball mill. Powder Technol. 27 (1980) 137-141
17. Krycer I., and Hersey J.A. Fine powder mixing in vibratory ball mill. Int. J. Pharm. (Kidlington) 6 (1980) 119-129
18. Liversidge G.G., and Cundy K.C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: absolute oral bioavailability of nanocrystalline danzol in beagle dogs. Int. J. Pharm. (Kidlington) 125 (1995) 1-97
19. Majerik V., Charbit G., Badens E., Horvath G., Szokonya L., Bosc N., and Teillaud E. Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. J. Supercrit. Fluids 40 (2007) 101-110
20. Marco I.D., and Reverchon E. Supercritical antisolvent micronization of cyclodextrins. Powder Technol. 183 (2008) 239-246
21. NIST Chemistry WebBook. http://webbook.nist.gov/chemistry (accessed 08.09).
22. Patel N.K., Upadhyay A.H., Bergum J.S., and Reier G.E. An evaluation of microcrystalline cellulose and lactose excipients using an instrumented single station tablet press. Int. J. Pharm. (Kidlington) 110 (1994) 203-210
23. Paul E.L., Atiemo-Obeng A., and Kresta S.M. Handbook of Industrial Mixing: Science and Practice (2003), Wiley-Interscience, New Jersey
24. Pereira B.G., Fonte-Boa F.D., Resende J.A.L.C., Pinheiro C.B., Fernandes N.G., Yoshida M.I., and Vianna-Soares C.N. Pseudopolymorphs and intrinsic dissolution of nevirapine. Cryst. Growth Des. 7 (2007) 2016-2023
25. Poux M., Fayolle P., and Bertrand J. Powder mixing: some practical rules applied to agitated systems. Powder Technol. 68 (1991) 213-234
26. Prescott J.K., and Barnum R.A. On the powder flowability. Pharm. Technol. 10 (2000) 60-84
27. Rasenack N., and Muller B.W. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm. Res. 19 (2002) 1894-1900
28. Rohrs B.R., Amidon G.E., Meury R.H., Secreast P.J., King H.M., and Skoug C.J. Particle size limits to meet USP content uniformity criteria for tablets and capsules. J. Pharm. Sci. 95 (2006) 1049-1059
29. Ruchatz F., Kleinebudde P., and Muller B.W. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process. J. Pharm. Sci. 86 (1997) 101-105
30. Sacha G.A., Schmitt W.J., and Nail S.L. Identification of critical process variables affecting particle size following precipitation using a supercritical fluid. Pharm. Dev. Technol. 11 (2006) 187-194
31. Sacha G.A., Schmitt W.J., and Nail S.L. Identification of physical-chemical variables affecting particle size following precipitation using supercritical fluid. Pharm. Dev. Technol. 11 (2006) 195-205
32. Sanganwar G.P., and Gupta R.B. Enhancement of shelf-life and handling properties of drug nanoparticles: mixing of itraconazole with silica at nanoscale. Ind. Eng. Chem. Res. 47 (2008) 4717-4725
33. 2. Powder Technol. 196 (2009) 36-49
34. Staniforth J.N. Advances in powder mixing and segregation in relation to pharmaceutical processing. Int. J. Pharm. Technol. Prod. Manuf. 3 (1982) 1-12
35. Swanepoel E., Liebenberg W., and Villiers M.M.D. Dissolution properties of proxicam powders and capsules as a function of particle size and the agglomeration of powders. Drug Dev. Ind. Pharm. 26 (2000) 1067-1076
36. Thakur R., Hudgins A.E., Goncalves E., and Muhrer G. Particle size and bulk powder flow control by supercritical antisolvent precipitation. Ind. Eng. Chem. Res. 48 (2009) 5302-5309
37. Thalberg K., Lindholm D., and Axelsson A. A comparison of different flowability tests for powders for inhalation. Powder Technol. 146 (2004) 206-213
38. Wishart D.S., Konx C., Guo A.C., Shrivastava S., Hassanali M., Stothard P., Chang Z., and Woolsey J. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34 (2006) D668-D672
39. Zwietering N.T. Suspending of solid particles in liquid by agitators. Chem. Eng. Sci. 8 (1958) 244-253